Skip to main content
User account menu
Log in
Search
Main navigation
Home
Data Sources
Studies
Institutions
Networks
Support
Home
University of Oslo
University of Oslo
First published
01/02/2024
Last updated
01/02/2024
Institution
Download as PDF
Page content
Institution identification
Institution description
Institution details
Contact
Institution identification
PURI
https://redirect.ema.europa.eu/resource/3331483
Institution ID
3331483
Institution full name and acronym
University of Oslo
ENCePP partner
No
Institution details
Experience with collecting data directly from individual patients or respondents:
No
Interest in carrying out research that is funded by pharmaceutical companies:
No
Network(s) of which the institution is a member
Data Analysis and Real World Interrogation Network (DARWIN EU®)
Data sources owned by the institution
This Institution does not have any datasource registered in the catalogue
Studies conducted by the institution
Clinical course, outcomes and risk factors of myocarditis and pericarditis following administration of Moderna vaccines targeting SARS-CoV-2.
CONSIGN study: COVID-19 infection and medicines in pregnancy - a multinational registry based study
Demonstrating solutions for studying intermittent medication exposures in diseases with episodic manifestations during pregnancy: application to medication for migraine in pregnancy
Description of international collaboration in the area of medicines use and effects in COVID-19 affected pregnancies (CONSIGN-International))
Exposure to SSRI/SNRI and depression in pregnancy and long-term childhood outcomes: the effect of modifying factors
Monitoring safety of Spikevax in pregnancy: an observational study using routinely collected health data in five European countries (COVID-19)
Post-Authorization Active Surveillance Safety Study Using Secondary Data to Monitor Real-World Safety of Spikevax in Europe (COVID-19)
Share this page